Back to Search
Start Over
Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis
- Source :
-
Clinical Biochemistry . Apr2010, Vol. 43 Issue 6, p576-580. 5p. - Publication Year :
- 2010
-
Abstract
- Abstract: Objective : Soluble receptor activator of nuclear factor-kappa B ligand (sRANKL) to osteoprotegerin ratio is designated as a bone metabolism equation in many rheumatologic disorders and would be modified with fish oil (FO) supplementation. Design and methods : Eighty-three females with rheumatoid arthritis were divided randomly to 40 and 43 patients treated with (1 g/day) or without FO for 3 months accompanied with conventional drugs, respectively. Osteoprotegerin, sRANKL, tumor necrosis factor alpha (TNFα) serum levels were measured before and after treatment. Results : Serum levels of osteoprotegerin increased, although sRANKL, TNFα and sRANKL/osteoprotegerin ratio decreased with FO therapy. A significant positive correlation was observed between sRANKL/osteoprotegerin ratio and TNFα levels (r =0.327, p =0.040) in the FO-treated group. Conclusions : FO could decrease the inflammatory response by lowering of serum TNFα levels and sRANKL/osteoprotegerin ratio. [Copyright &y& Elsevier]
Details
- Language :
- English
- ISSN :
- 00099120
- Volume :
- 43
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Clinical Biochemistry
- Publication Type :
- Academic Journal
- Accession number :
- 48729965
- Full Text :
- https://doi.org/10.1016/j.clinbiochem.2009.12.011